ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.035,69
-1,57%
US Dollar vs BRL
5,1959
1,51%
Bitcoin
60.099,29
-5,83%
Brent Oil
85,93
-1,55%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Willow Biosciences Inc (WLLW)

  7. Willow Biosciences Inc (WLLW) Notícias

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:WLLW
DataHoraFonteTítuloCódigoCompanhia
28/03/202420:30PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
29/02/202420:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
20/02/202420:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
31/01/202409:00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
16/01/202409:00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
10/01/202409:00PR Newswire (US)WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023TSX:WLLWWillow Biosciences Inc
07/12/202309:00PR Newswire (US)WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
10/10/202320:52PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
03/10/202308:00PR Newswire (US)WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONTSX:WLLWWillow Biosciences Inc
12/09/202308:00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
06/09/202308:00PR Newswire (Canada)WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCATSX:WLLWWillow Biosciences Inc
30/08/202308:00PR Newswire (US)WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTTSX:WLLWWillow Biosciences Inc
24/08/202308:00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORMTSX:WLLWWillow Biosciences Inc
21/08/202308:00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
08/08/202318:10PR Newswire (US)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSTSX:WLLWWillow Biosciences Inc
20/07/202308:00PR Newswire (US)WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODSTSX:WLLWWillow Biosciences Inc
31/05/202308:00PR Newswire (US)WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASESTSX:WLLWWillow Biosciences Inc
23/05/202308:00PR Newswire (Canada)KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENTTSX:WLLWWillow Biosciences Inc
12/05/202318:04PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTSTSX:WLLWWillow Biosciences Inc
11/05/202321:58PR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTSTSX:WLLWWillow Biosciences Inc
19/04/202312:35AllPennyStocks.comCommercial Agreement Sends Micro Cap SoaringTSX:WLLWWillow Biosciences Inc
18/04/202317:30PR Newswire (US)WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONETSX:WLLWWillow Biosciences Inc
12/04/202317:30PR Newswire (Canada)WILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURINGTSX:WLLWWillow Biosciences Inc
28/03/202317:10PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENTTSX:WLLWWillow Biosciences Inc
22/03/202308:00PR Newswire (Canada)WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAYTSX:WLLWWillow Biosciences Inc
21/03/202319:49PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIFTSX:WLLWWillow Biosciences Inc
22/02/202309:00PR Newswire (US)WILLOW ANNOUNCES APPOINTMENT OF DR. JIM LALONDE TO BOARD OF DIRECTORSTSX:WLLWWillow Biosciences Inc
17/01/202309:00PR Newswire (US)WILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT PHASE OF PARTNERED PHARMACEUTICAL PROJECTTSX:WLLWWillow Biosciences Inc
14/12/202209:00PR Newswire (US)WILLOW PROVIDES CORPORATE UPDATES, BUSINESS OUTLOOK AND KEY TARGETED MILESTONES ANTICIPATED FOR 2023 TO EXPAND GROWTHTSX:WLLWWillow Biosciences Inc
07/12/202209:00PR Newswire (US)WILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON NEAR-TERM REVENUE GENERATION AND REDUCE CASH BURNTSX:WLLWWillow Biosciences Inc
 Apresentando as notícias mais relevantes sobre:TSX:WLLW

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
TECN3
TECHNOS ON
BOV
EMAE4
EMAE PN
BOV
GOLL4
GOL PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
OIBR3
OI ON
BOV
HBOR3
HELBOR ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
BRKM5
BRASKEM PNA
BOV
SGPS3
SPRINGS ON
BOV
LUPA3
LUPATECH ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados